Neuropathy
Minor or subclinical neuromuscular complications of drugs are common (Hudgson 1982) ,but these are often not important in clinical practice. For example, a subclinical neuropathy may occur in patients treated with phenytoin (Lovelace & Horwitz 1968 ) and this is sometimes evident by decreased distal reflexes and mild distal sensory impairment. Electrophysiological studies have revealed slowed sensory and motor nerve conduction velocity, with reduced sensory potential amplitudes in 50% of patients treated with anticonvulsant drugs for 2 to 30 years (Danner et al. 1981) . These electrophysiological abnormalities are more prominent in patients treated with larger doses of anticonvulsant drugs (Eisen et al. 1974 ), but they are not usually accompanied by symptoms of peripheral neuropathy. Several other drugs may induce subclinical peripheral neuropathy, for example, indomethacin, nalidixic acid and chlorpropamide.
More severe neuropathies occur with several different groups of drugs. Sensorimotor neuropathy, often with unpleasant dysaesthesiae, is an almost invariable complication of cytotoxic drug therapy. Vincristine, chlorambucil, procarbazine and cytosine arabinoside are particularly well known examples. Some of these drugs induce predominantly sensory symptoms, but in' most patients there is clinical and electrophysiological evidence of involvement of both motor and sensory nerve fibres. Perhexiline and metronidazole may also cause severe neuropathy. Only one in 1000 patients treated with perhexiline develop a severe sensorimotor neuropathy, which may be accompanied by a myopathy, but as many as 65% show electrophysiological evidence of a subclinical neuropathy (Sebille 1978 
Disordered neuromuscular transmission
A number of drugs, particularly those used in anaesthesia, may interfere with neuromuscular transmission. For example, respiratory depression may occur in patients treated with neomycin, gentamicin or polymyxin before anaesthesia; these drugs have a mild neuromuscular blocking effect. Quinidine may have a similar effect when given postoperatively in patients treated with muscle relaxants during anaesthesia (Way et al. 1967) . Muscle relaxant drugs themselves may have an unexpectedly profound or long effect in patients with subclinical or overt myasthenia gravis, and a similar enhancement of underlying myasthenia may result from treatment with neomycin and other antibiotics, phenytoin, troxidone, psychotrophic drugs, lithium and imipramine (Argo v & Mastaglia 1979) . Penicillamine may induce true myasthenia gravis with raised circulating acetylcholine receptor antibody levels, both in patients with rheumatoid arthritis and Wilson's disease (Masters et al. 1977) . When penicillamine treatment is stopped, the myasthenia slowly improves.
Myopathy
The most common drug-induced myopathy is steroid myopathy (Swash & Schwartz 1981) .
The development of the myopathy is probably dose-related although individual susceptibility is also a factor. Prednisone in a dose of 100 mg daily may produce symptomatic myopathy within a month, whereas 15 mg is unlikely to cause myopathy unless continued for several years (Afifi et al. 1968 ). Fluorinated steroids are more likely to induce myopathy at low dosage. When the steroid is stopped, the myopathy slowly improves. A particular problem arises in patients with inflammatory myopathy treated with steroids, since it is sometimes difficult to decide whether residual or increasing weakness is due to the disease itself or to steroid therapy (Askari et al. 1976 ). Reduction of steroid dosage is worthwhile, and muscle biopsy may also be useful in this problem. In steroid myopathy weakness is not associated with pain; although there may be profound muscular wasting.
Acute, or subacute, painful, proximal weakness may develop in patients treated with emetine, epsilon aminocaproic acid (Kennard et al. 1980) , clofibrate, cimetidine and penicillamine. These myopathies are characterized by necrosis of muscle with raised blood creatine kinase levels: recovery occurs when the causative drug is stopped. Penicillamine and procainamide may rarely induce an inflammatory myopathy resembling polymyositis. Hypokalaemia, due to diuretic or purgative abuse or to liquorice or alcohol ingestion, may also present as painful proximal weakness.
Acute rhabdomyolysis, with myoglobinuria, is a rare complication of treatment with phenformin. It occurs more commonly after poisoning with phenobarbitone and carbon monoxide, and also occurs in opiate addiction and in acute alcoholic myopathy. Malignant hyperpyrexia is a rare inherited disorder, in which anaesthetic agents induce sudden hyperpyrexia. Susceptible patients may have a subclinical myopathy detectable by muscle biopsy and by an in vitro test (Moulds & Denborough 1974) . A wide range of anaesthetic drugs may induce the hyperpyrexia (Ellis & Halsall 1980) and tricyclic antidepressant drugs and monoamine oxidase inhibitors have also been incriminated.
Diagnosis
The diagnosis of a drug-induced neuromuscular disorder can usually be suspected from the clinical features, particularly from the history of drug exposure.
Drug-induced neuropathies. usually present with dysaesthesiae in the distal parts of the limbs, but weakness may be only slight; the distal tendon reflexes are invariably diminished or absent. The diagnosis can be confirmed by motor and sensory nerve conduction studies (Swash & Schwartz 1981) and by the improvement which slowly occurs when the offending drug is withdrawn.
Drug-induced disturbances of neuromuscular transmission may be mild, or severe enough to cause respiratory embarrassment. The response to intravenous edrophonium will usually confirm the diagnosis; electrophysiological studies using repetitive nerve stimulation or single fibre electromyography (Swash & Schwartz 1981) are particularly useful in mild cases. The presence of underlying myasthenia gravis, enhanced by the drug, can be confirmed by measuring circulating acetylcholine receptor antibody levels (Lindstrom et al. 1976 ).
Drug-induced myopathies are often associated with increased blood creatine kinase levels. Electrolyte disturbances, particularly hypokalaemia, should always be considered. Myoglobinuria may occur when there is acute severe muscle necrosis.
In certain circumstances, e.g. steroid myopathy, when anaesthetic drugs are used in myasthenic patients or when isoniazid is used in tuberculosis, the development of a neuromuscular complication can be predicted and appropriate measures taken. A full drug history is an important part of the evaluation of any patient presenting with neuromuscular symptoms.
